Company:  TRANSENTERIX INC. (TRXC)
Form Type:  10-K
Filing Date:  4/1/2013 
CIK:  0000876378 
Address:  635 DAVIS DRIVE
SUITE 300
 
City, State, Zip:  MORRISVILLE, North Carolina 27560 
Telephone:  919-765-8400 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$2.22  
Change: 
-0.14 (-5.93%)  
Trade Time: 
Mar 22  
Market Cap: 
$481.83M
Trade TRXC now with 

© 2019  
Description of Business
TransEnterix is a medical device company that is digitizing the interface between the surgeon and the patient in laparoscopy to increase control and reduce surgical variability in today's value-based healthcare environment. We are focused on the commercialization of our Senhance(TM) System, that digitizes laparoscopic minimally invasive surgery. The Senhance System allows for robotic precision, haptic feedback, surgeon camera control via eye sensing and improved ergonomics while offering responsible economics. We believe pressures are increasing on hospitals and surgeons under the constraints of value-based healthcare, particularly in the areas of operating room inefficiencies, surgical variability and workforce challenges.
Register and access this filing in:     
  FORM 10-K
    PART I
      Item 1. Business.
      Item 1A. Risk Factors.
      Item 2. Properties.
      Item 3. Legal Proceedings.
      Item 4. Mine Safety Disclosures.
    PART II
      Item 5. Market for Registrant's Common Equity, Related ...
      Item 6. Selected Financial Data.
      Item 7. Management's Discussion and Analysis of Financial ...
        Results of Operations
        Liquidity and Capital Resources
      Item 7A. Quantitative and Qualitative Disclosures About ...
      Item 8. Financial Statements and Supplementary Data.
        REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
          NOTE 14 - SUBSEQUENT EVENTS
      Item 9. Changes in and Disagreements with Accountants on ...
      Item 9A. Controls and Procedures.
      Item 9B. Other Information.
    PART III
      Item 10. Directors, Executive Officers and Corporate Governance.
      Item 11. Executive Compensation.
      Item 12. Security Ownership of Certain Beneficial Owners and ...
      Item 13. Certain Relationships and Related Transactions, and ...
      Item 14. Principal Accounting Fees and Services.
    PART IV
      Item 15. Exhibits, Financial Statement Schedules
    SIGNATURES
  EXHIBIT 21.1
    SUBSIDIARIES
  EXHIBIT 23.1
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
  EXHIBIT 31.1
    CERTIFICATIONS
  EXHIBIT 31.2
    CERTIFICATIONS
  EXHIBIT 32.1
    CERTIFICATION PURSUANT
  EXHIBIT 32.2
    CERTIFICATION PURSUANT